GTC-5000

N/A

Report date: 2025/01/26 17:28:53
NME

Base Information

Drug NameGTC-5000
Drug Alias NameGTC-5000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynuclein alpha modulatorsGlycosaminoglycan modulators
TargetsSynuclein alphaGlycosaminoglycan
Therapy Area/IndicationsNerve DegenerationParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGismo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGismo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A